Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-05T22:20:37.504Z Has data issue: false hasContentIssue false

320 - Barriers to Deprescribing in Older Adults with Dementia

Published online by Cambridge University Press:  04 November 2020

Mariana Duarte-Mangas
Affiliation:
Gonçalo A. Santos
Affiliation:
Beatriz Jorge
Affiliation:
Catarina Pedro Fernandes
Affiliation:
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Individuals with dementia usually have multiple chronic illnesses, most of whom are medicated with five or more medications. However, as dementia progresses and the goal of care moves from prolonging life to optimizing quality of life, the risk of taking certain medications may outweigh its benefit. Therefore, it is necessary to reassess the medication over time.

The objective of this work was to explore the barriers to optimising prescribing and deprescribing (withdrawing) of medications and the benefits of this procedure. Optimizing pharmacological treatment for people with dementia usually requires the prescription of inappropriate drugs and the initiation of other drugs. Several obstacles to the optimization of treatment have been identified in elderly people with multiple morbidities, related to the doctor, the health system, the patient and the caregiver, including: inadequate guidelines, incomplete medical history, prevention of negative consequences and established beliefs in the benefits and harms medication. Desprescribing older people with dementia is made even more difficult by the decrease in decision-making capacity, difficulties in understanding and communicating, increased involvement of caregivers and difficulties in setting goals.

Type
Abstract
Copyright
© International Psychogeriatric Association 2020